ArticleRegenerative therapy2025

Optimizing the commercial manufacturing of tisagenlecleucel for patients in Japan: A 4-year experiential journey.

Fumiko Iwamoto et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.